- Home
- RLAY vs EROC Comparison
RLAY vs EROC Comparison
Compare RLAY & EROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$18.41
Company Overview
Basic Information| Metric | RLAY | EROC |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.5B |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | RLAY | EROC |
|---|---|---|
| Price | $18.41 | $7.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $27.58 | $22.13 |
| AVG Volume (30 Days) | 2.4M | ★ 3.1M |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $146.63 |
| Revenue Next Year | $60.15 | $214.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $5.95 | $7.30 |
| 52 Week High | $21.27 | $17.98 |
Technical Indicators
Market Signals| Indicator | RLAY | EROC |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 36.31 |
| Support Level | $17.45 | N/A |
| Resistance Level | $20.31 | $14.06 |
| Average True Range (ATR) | 1.15 | 0.80 |
| MACD | -0.04 | -0.10 |
| Stochastic Oscillator | 44.29 | 24.60 |
Price Performance
Historical Comparison RLAY
EROC
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.